Physician profile
Ana Carolina Victoria
NPI 1114217551
$130,019.85
in general payments reported to CMS, 2019-2025
52 companies · $15K in 2025
The $15K reported for 2025 was more than what 93% of Ophthalmic Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $299).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,111 · 2020: $4,698 · 2021: $6,615 · 2022: $10K · 2023: $40K · 2024: $51K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Honoraria: $31K · Consulting Fee: $17K · Food and Beverage: $16K · Travel and Lodging: $8,270 · Education: $133 · Gift: $43.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,797.50 |
| Honoraria | $31,150.00 |
| Consulting Fee | $16,567.50 |
| Food and Beverage | $16,220.90 |
| Travel and Lodging | $8,269.76 |
| Education | $132.62 |
| Gift | $43.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $52,716.14 | 2024-2025 | Tepezza, Krystexxa |
| Horizon Therapeutics Plc | $47,930.55 | 2019-2023 | Tepezza |
| Galderma Laboratories, L.P. | $4,346.74 | 2019-2025 | Dysport |
| Abbvie INC. | $4,159.68 | 2022-2025 | Durysta, Botox, Lumigan |
| Mallinckrodt Hospital Products INC. | $3,828.66 | 2020-2025 | Acthar |
| Alcon Vision LLC | $1,652.24 | 2020-2025 | Simbrinza, Clareon, Eysuvis |
| Sun Pharmaceutical Industries INC. | $1,393.98 | 2020-2025 | Cequa |
| Bausch & Lomb Americas INC. | $1,325.88 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Allergan, INC. | $1,286.99 | 2019-2022 | |
| Oyster Point Pharma, INC. | $938.70 | 2022-2025 | Tyrvaya, Ryzumvi |
| Trice Medical, INC. | $919.87 | 2021-2025 | |
| Biotissue Holdings INC. | $752.23 | 2020-2025 | |
| Sientra, INC. | $696.54 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $633.93 | 2019-2022 | |
| Harrow Eye, LLC | $633.93 | 2024-2025 | Vevye |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $519.52 | 2024-2025 | Daxxify |
| Dompe US, INC. | $483.85 | 2021-2022 | |
| Mallinckrodt Enterprises LLC | $468.01 | 2019 | |
| Novartis Pharmaceuticals Corporation | $464.54 | 2019-2023 | |
| Thea Pharma INC. | $437.83 | 2022-2025 | Iyuzeh |
| Regeneron Healthcare Solutions, INC. | $360.45 | 2022-2025 | Eylea, Eylea Hd |
| Eyevance Pharmaceuticals LLC | $332.37 | 2019-2022 | |
| Axogen | $331.05 | 2021-2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Merz North America, INC. | $297.19 | 2019-2024 | |
| Astellas Pharma US INC | $280.11 | 2024-2025 | Izervay |
| Omeros Corporation | $261.12 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $247.02 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $246.45 | 2020-2021 | |
| Tarsus Pharmaceuticals, INC. | $229.85 | 2024-2025 | Xdemvy |
| Ani Pharmaceuticals, INC. | $206.01 | 2023-2025 | Purified Cortrophin Gel, Iluvien |
| Poriferous LLC | $180.92 | 2022 | |
| Aerie Pharmaceuticals, INC. | $159.70 | 2019-2020 | |
| Rayner Intraocular Lenses Limited | $142.71 | 2023-2024 | Omidria, Rayone Aspheric, Rayone Spheric |
| Johnson & Johnson Surgical Vision, INC. | $136.85 | 2020-2021 | |
| Merz Pharmaceuticals, LLC | $130.33 | 2021-2025 | Xeomin |
| Vertex Pharmaceuticals Incorporated | $121.87 | 2025 | |
| Apellis Pharmaceuticals, INC. | $111.79 | 2023-2024 | Syfovre |
| Alafair Biosciences, INC. | $101.99 | 2024 | Versawrap |
| Halozyme INC | $98.81 | 2023-2025 | Hylenex Recombinant |
| Katalyst Surgical, LLC | $72.47 | 2023 | |
| Sight Sciences, INC. | $66.25 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| Rxsight INC | $62.03 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Genentech USA, INC. | $54.57 | 2025 | Vabysmo |
| Glaukos Corporation | $47.95 | 2025 | Idosetr |
| Dutch Ophthalmic, USA | $26.44 | 2022 | |
| Shire North American Group INC | $22.30 | 2019 | |
| Akorn, INC. | $19.46 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Kedrion Biopharma, INC. | $16.94 | 2024 | Rhogam Ultra-Filtered Plus, Albuked, Koate |
| Carl Zeiss Meditec, INC. | $16.83 | 2019 | |
| Janssen Biotech, INC. | $14.76 | 2019 | |
| Quidel Corporation | $14.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ana Victoria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.